Colgate-Palmolive (NYSE:CL) Stock Rating Lowered by StockNews.com

Colgate-Palmolive (NYSE:CL) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Friday.

Several other equities research analysts have also commented on the company. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Barclays cut their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Finally, Raymond James reiterated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $101.72.

Colgate-Palmolive Trading Down 0.8 %

NYSE CL opened at $89.80 on Friday. The business’s 50-day moving average price is $89.02 and its two-hundred day moving average price is $94.74. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The firm has a market capitalization of $72.87 billion, a PE ratio of 25.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the business posted $0.87 EPS. On average, analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Institutional Trading of Colgate-Palmolive

A number of institutional investors and hedge funds have recently modified their holdings of the business. Northstar Financial Companies Inc. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $331,000. Mattson Financial Services LLC bought a new position in Colgate-Palmolive during the fourth quarter valued at $264,000. Wood Tarver Financial Group LLC bought a new position in Colgate-Palmolive during the fourth quarter valued at $48,000. GHE LLC grew its holdings in Colgate-Palmolive by 1.7% during the fourth quarter. GHE LLC now owns 21,288 shares of the company’s stock valued at $1,935,000 after purchasing an additional 350 shares during the period. Finally, Menard Financial Group LLC bought a new position in Colgate-Palmolive during the fourth quarter valued at $102,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.